The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA COVID-19 Vaccine Market Research Report 2024
Synopsis
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
Global mRNA COVID-19 Vaccine market is projected to reach US$ 4430.4 million in 2029, increasing from US$ 4230 million in 2022, with the CAGR of 1.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole mRNA COVID-19 Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global mRNA COVID-19 Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Segment by Type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Segment by Application
Children
Adults
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The mRNA COVID-19 Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
Global mRNA COVID-19 Vaccine market is projected to reach US$ 4430.4 million in 2029, increasing from US$ 4230 million in 2022, with the CAGR of 1.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole mRNA COVID-19 Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global mRNA COVID-19 Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Segment by Type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Segment by Application
Children
Adults
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The mRNA COVID-19 Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 mRNA COVID-19 Vaccine Market Overview
1.1 Product Overview and Scope of mRNA COVID-19 Vaccine
1.2 mRNA COVID-19 Vaccine Segment by Type
1.2.1 Global mRNA COVID-19 Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Non-replicating mRNA Vaccine
1.2.3 Self-amplifying mRNA Vaccine
1.3 mRNA COVID-19 Vaccine Segment by Application
1.3.1 Global mRNA COVID-19 Vaccine Market Value by Application: (2023-2029)
1.3.2 Children
1.3.3 Adults
1.4 Global mRNA COVID-19 Vaccine Market Size Estimates and Forecasts
1.4.1 Global mRNA COVID-19 Vaccine Revenue 2018-2029
1.4.2 Global mRNA COVID-19 Vaccine Sales 2018-2029
1.4.3 Global mRNA COVID-19 Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 mRNA COVID-19 Vaccine Market Competition by Manufacturers
2.1 Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global mRNA COVID-19 Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global mRNA COVID-19 Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of mRNA COVID-19 Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA COVID-19 Vaccine, Product Type & Application
2.7 mRNA COVID-19 Vaccine Market Competitive Situation and Trends
2.7.1 mRNA COVID-19 Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest mRNA COVID-19 Vaccine Players Market Share by Revenue
2.7.3 Global mRNA COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 mRNA COVID-19 Vaccine Retrospective Market Scenario by Region
3.1 Global mRNA COVID-19 Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global mRNA COVID-19 Vaccine Global mRNA COVID-19 Vaccine Sales by Region: 2018-2029
3.2.1 Global mRNA COVID-19 Vaccine Sales by Region: 2018-2023
3.2.2 Global mRNA COVID-19 Vaccine Sales by Region: 2024-2029
3.3 Global mRNA COVID-19 Vaccine Global mRNA COVID-19 Vaccine Revenue by Region: 2018-2029
3.3.1 Global mRNA COVID-19 Vaccine Revenue by Region: 2018-2023
3.3.2 Global mRNA COVID-19 Vaccine Revenue by Region: 2024-2029
3.4 North America mRNA COVID-19 Vaccine Market Facts & Figures by Country
3.4.1 North America mRNA COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America mRNA COVID-19 Vaccine Sales by Country (2018-2029)
3.4.3 North America mRNA COVID-19 Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA COVID-19 Vaccine Market Facts & Figures by Country
3.5.1 Europe mRNA COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe mRNA COVID-19 Vaccine Sales by Country (2018-2029)
3.5.3 Europe mRNA COVID-19 Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA COVID-19 Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific mRNA COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific mRNA COVID-19 Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific mRNA COVID-19 Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA COVID-19 Vaccine Market Facts & Figures by Country
3.7.1 Latin America mRNA COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America mRNA COVID-19 Vaccine Sales by Country (2018-2029)
3.7.3 Latin America mRNA COVID-19 Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa mRNA COVID-19 Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa mRNA COVID-19 Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa mRNA COVID-19 Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global mRNA COVID-19 Vaccine Sales by Type (2018-2029)
4.1.1 Global mRNA COVID-19 Vaccine Sales by Type (2018-2023)
4.1.2 Global mRNA COVID-19 Vaccine Sales by Type (2024-2029)
4.1.3 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2018-2029)
4.2 Global mRNA COVID-19 Vaccine Revenue by Type (2018-2029)
4.2.1 Global mRNA COVID-19 Vaccine Revenue by Type (2018-2023)
4.2.2 Global mRNA COVID-19 Vaccine Revenue by Type (2024-2029)
4.2.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global mRNA COVID-19 Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global mRNA COVID-19 Vaccine Sales by Application (2018-2029)
5.1.1 Global mRNA COVID-19 Vaccine Sales by Application (2018-2023)
5.1.2 Global mRNA COVID-19 Vaccine Sales by Application (2024-2029)
5.1.3 Global mRNA COVID-19 Vaccine Sales Market Share by Application (2018-2029)
5.2 Global mRNA COVID-19 Vaccine Revenue by Application (2018-2029)
5.2.1 Global mRNA COVID-19 Vaccine Revenue by Application (2018-2023)
5.2.2 Global mRNA COVID-19 Vaccine Revenue by Application (2024-2029)
5.2.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global mRNA COVID-19 Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Moderna mRNA COVID-19 Vaccine Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer mRNA COVID-19 Vaccine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Fosun-Pharmaceutical
6.4.1 Fosun-Pharmaceutical Corporation Information
6.4.2 Fosun-Pharmaceutical Description and Business Overview
6.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio
6.4.5 Fosun-Pharmaceutical Recent Developments/Updates
6.5 CSPC Pharmaceutical
6.5.1 CSPC Pharmaceutical Corporation Information
6.5.2 CSPC Pharmaceutical Description and Business Overview
6.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio
6.5.5 CSPC Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA COVID-19 Vaccine Industry Chain Analysis
7.2 mRNA COVID-19 Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA COVID-19 Vaccine Production Mode & Process
7.4 mRNA COVID-19 Vaccine Sales and Marketing
7.4.1 mRNA COVID-19 Vaccine Sales Channels
7.4.2 mRNA COVID-19 Vaccine Distributors
7.5 mRNA COVID-19 Vaccine Customers
8 mRNA COVID-19 Vaccine Market Dynamics
8.1 mRNA COVID-19 Vaccine Industry Trends
8.2 mRNA COVID-19 Vaccine Market Drivers
8.3 mRNA COVID-19 Vaccine Market Challenges
8.4 mRNA COVID-19 Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
